4.4 Review

Cholesterol-metabolizing cytochromes P450

期刊

DRUG METABOLISM AND DISPOSITION
卷 34, 期 4, 页码 513-520

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/dmd.105.008789

关键词

-

资金

  1. NIA NIH HHS [AG024336] Funding Source: Medline
  2. NIGMS NIH HHS [GM62882] Funding Source: Medline

向作者/读者索取更多资源

By catalyzing the first steps in different pathways of cholesterol degradation, cytochromes P450 ( P450s) 7A1, 27A1, 11A1, and 46A1 play key roles in cholesterol homeostasis. CYP7A1 is a microsomal liver- specific enzyme that converts cholesterol to 7 alpha- hydroxycholesterol. CYP27A1 is a ubiquitously expressed mitochondrial P450 that metabolizes cholesterol to 27- hydroxycholesterol. CYP11A1 also resides in mitochondria but is expressed mainly in steroidogenic tissues, where it catalyzes the conversion of cholesterol to pregnenolone. Finally, CYP46A1 is a brain- selective microsomal monooxygenase producing 24S- hydroxycholesterol from cholesterol. Catalytic efficiencies of cholesterol- metabolizing P450s vary significantly and probably reflect physiological requirements of different organs for the rate of cholesterol turnover. P450s 7A1, 27A1, 11A1, and 46A1 represent a unique system for elucidation of how different enzymes have adapted to fit their specific roles in cholesterol elimination. Studies of cholesterol- metabolizing P450s suggest that their activities could be modulated post- translationally and that they should also be considered as targets for regulation of cholesterol homeostasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据